Purpose This double-blind, multicenter trial compared the efficacy and safety of a single
daily oral dose of moxifloxacin with oral combination therapy in low-risk febrile neutropenic …

BACKGROUND Oral‐based antibiotic therapy is the standard of care in the management of
cancer patients with low‐risk neutropenic fever. Nevertheless, to the authors' knowledge, the …

Goals of work Patients with low-risk neutropenic fever as defined by the Multinational
Association of Supportive Care in Cancer (MASCC) score might benefit from ambulatory …

To assess the efficacy of ciprofloxacin in neutropenic patients, we conducted a randomized
prospective trial comparing the combination of ciprofloxacin and netilmicin against …

Objectives Low-risk febrile neutropenic patients can be treated without hospitalization with
oral antibiotic regimens. Combination regimens are recommended. Our objective was to …

Background Among patients with fever and neutropenia during cancer chemotherapy who
have a low risk of complications, oral administration of empirical broad-spectrum antibiotics …

BACKGROUND Hospitalization and treatment with broad‐spectrum intravenous antibiotics
is the standard care for patients with neutropenia and fever. This randomized clinical trial …

Aminoglycoside-containing combination therapy has been the standard empirical approach
for febrile neutropenic cancer patients. With the advent of the broad-spectrum oral …

Infectious complications are an important cause of morbidity and mortality in cancer patients,
especially those receiving chemotherapy. Furthermore, neutropenia, fever and infection limit …

Purpose To provide guidelines on antimicrobial prophylaxis for adult neutropenic oncology
outpatients and on selection and treatment as outpatients of those with fever and …